Introduction

Sarcopenia is a geriatric syndrome characterized by a significant loss of skeletal muscle mass and a marked decline in muscle strength with age.1–3 It is triggered by persistent loss of skeletal muscle mass and a decline in muscle strength and function.2 Given the central role of skeletal muscle in the body’s locomotor system, atrophy and dysfunction of this tissue are significant indicators of aging. Such conditions can result in various health complications, including fractures and joint damage.4,5 The senior people with sarcopenia may experience instability and staggering, increasing their risk of falls and subsequent fractures.6,7 Furthermore, sarcopenia has a detrimental effect on the body’s metabolic function, potentially resulting in diabetes, cardiovascular disease, lung failure, and even endangering one’s life.1,8

The prevalence of sarcopenia is known to increase with age. Although the prevalence varies depending on the diagnostic criteria and study population,9,10 it is generally recognized that sarcopenia affects 10–20% of the senior people over the age of 60 years, and this rate may climb to over 30% by the age of 80 years.11–13 The development of sarcopenia is a multifactorial process that involves genetics, neurological decline, decreased mitochondrial function in skeletal muscle, fatty infiltration, lack of exercise, chronic diseases, and malnutrition.2,14,15 It is important to note that sarcopenia is more prevalent in patients with chronic diseases than in the general population, with rates ranging from 18% in patients with diabetes to 66% in patients diagnosed with cancer.16

Vitamin D is an essential fat-soluble vitamin for human health.17 Its physiological functions are diverse and cover many core areas, including regulating calcium and phosphorus metabolism, maintaining bone health, and regulating immune function.18–20 There are two primary forms of vitamin D: vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol).21 Vitamin D3 is primarily synthesized naturally in the skin through sunlight exposure, but it can also be obtained from food sources such as cod liver oil and egg yolks.18,21,22 After entering the body, vitamin D undergoes hydroxylation in the liver to form 25-hydroxyvitamin D (25(OH)D), the primary circulating form of the vitamin in the bloodstream. In the kidneys, (25(OH)D) is hydroxylated to form the biologically active 1.25-dihydroxyvitamin D.23,24 This active form binds to the vitamin D receptor (VDR) in target cells, regulating the expression of relevant genes and allowing for fine-tuned regulation of calcium and phosphorus metabolism, cellular differentiation, and other vital physiological processes.17–20

Vitamin D is essential for maintaining bone and muscle health. It facilitates the absorption of calcium and phosphorus in the intestines, which are necessary minerals for building bone. Additionally, it stimulates the synthesis and mineralization of bone matrix by directly acting on osteoblasts, promoting bone growth and maturation. Vitamin D regulates blood calcium and phosphorus metabolism, maintaining their balance. This is crucial for keeping bones strong and stable.19 Vitamin D inhibits the activity of osteoclasts and reduces bone resorption, thus maintaining bone density and preventing bone diseases such as osteoporosis and fractures. Additionally, it has an essential impact on muscle function. Research has unequivocally demonstrated that vitamin D receptors are widely present in muscle tissue, and vitamin D directly impacts the differentiation and metabolism of muscle cells to ensure normal muscle function.25,26 A deficiency in vitamin D unequivocally reduces muscle strength and increases the risk of falls due to fatigue.27,28 Furthermore, vitamin D plays an indirect yet crucial role in maintaining overall skeletal muscle health by regulating the immune and neuromuscular systems.26

In recent years, research on the relationship between vitamin D and sarcopenia has received increased attention due to its potential significance. Many studies have examined the relationship between vitamin D levels and sarcopenia and have reached some meaningful conclusions. Some studies have demonstrated a significant correlation between vitamin D deficiency and an elevated risk of sarcopenia. However, not all studies have yielded consistent results, and some have also failed to observe a significant association between vitamin D levels and sarcopenia. These discrepancies in findings may be attributed to many factors, including study design, sample size, selection of study participants, definition of vitamin D deficiency, and diagnostic criteria for sarcopenia. Nevertheless, most studies continue to support the crucial role of vitamin D in maintaining skeletal muscle health and suggest that vitamin D deficiency may be an independent risk factor for sarcopenia. Therefore, a comprehensive investigation of the relationship between vitamin D and sarcopenia is of significant scientific and practical importance and will positively impact the quality of life of the senior people.

Vitamin D Deficiency and the Incidence of Sarcopenia in the Senior People

Several studies have shown a strong association between vitamin D deficiency and sarcopenia in the senior people. The prevalence of vitamin D deficiency in the senior people ranges from 17.4% to 87%.29 This decrease in serum vitamin D levels is attributed to inadequate intake,30 lack of sun exposure,31 skin pigmentation,32 and absorption inhibition.33 The senior people, in particular, have lower levels of 7-dehydrocholesterol in their skin, resulting in less vitamin D production from sunlight.34 This, in turn, increases the risk of vitamin D deficiency in this population. Recent studies have shown that the skin produces about 13% less vitamin D per decade, meaning that 70-year-old subjects produce only half as much vitamin D as 20-year-old subjects.35 It is worth noting that the vitamin D status of older hospitalized patients is particularly concerning.36 As the skin’s ability to synthesize vitamin D declines and kidney function deteriorates with age, there is a corresponding decrease in the conversion of vitamin D to its active form, 1.25-dihydroxyvitamin D.37 This deficiency ultimately leads to reduced stimulation of the VDR.37 VDR expression decreases with age, reducing sensitivity to 1.25-dihydroxyvitamin D.38 Furthermore, there is an association between iron deficiency, anemia, and vitamin D deficiency.39,40 This suggests combining these nutritional deficiencies will create a greater risk for muscle health and inflammation.29,41

Multiple academic studies have confirmed a significant positive correlation between vitamin D deficiency and loss of muscle strength.42–44 Low levels of serum (25(OH)D) are strongly associated with the loss of muscle strength45–47 and impairment of physical function.48–50 Vitamin D deficiency can lead to muscle abnormalities, such as type II fibrous atrophy, infiltration of adipocytes and glycogen granules in the muscle, enlarged fibrous gaps, and increased fibrosis.51 A recent report by Yang et al52 suggests that the combination of low serum vitamin D levels and lack of exercise can further exacerbate muscular atrophy in the senior people. Bang et al53 demonstrated that older women with vitamin D deficiency had significantly lower lumbar muscle strength and a higher percentage of fat infiltration in paraspinal muscles compared to the control and vitamin D-sufficient groups. Furthermore, various studies in the senior people have indicated that lower vitamin D levels are significantly associated with reduced muscle strength and physical activity.54,55 Research has shown a significant correlation between vitamin D deficiency, decreased muscle function, and an increased risk of sarcopenia in humans.56 In the senior people, serum vitamin D levels may predict the decline in skeletal muscle function and atrophy with age, and its deficiency may significantly increase the risk of sarcopenia.57,58

The academic community has produced a range of findings regarding exploring the link between vitamin D deficiency and sarcopenia in the senior population. While the majority of studies tend to conclude that there is a strong association between the two, some studies still fail to reveal this interconnection. Table 1 summarizes a series of relevant studies to dissect the potential association between vitamin D deficiency and sarcopenia in the senior population.

Table 1 Studies About Sarcopenia and Vitamin D in Senior People

In particular, the findings of several studies indicate a positive correlation between vitamin D deficiency and sarcopenia in older adults. For example, a paired case-control study conducted by Yang et al56 demonstrated that vitamin D deficiency (serum 25(OH)D < 20 ng/mL) was significantly associated with an increased risk of sarcopenia in a community-dwelling group of older adults (OR = 7.75, 95% CI: 1.96–30.71). Similarly, two cross-sectional studies by Lawongsa et al59 and Kim et al60 corroborated the assertion that vitamin D deficiency represents a significant risk factor for sarcopenia.

The complexity of this association is further revealed by gender-specific analyses, with negative associations between 25(OH)D concentrations and sarcopenia confirmed in a study of men aged 65 years and older by Kim et al61 and in a study of postmenopausal women by Lee et al.62 However, the opposite conclusion, In contrast, the study by Park et al and Luo et al yielded different results. The study by Park et al,63 which included 5263 participants aged 50 years and older, revealed a strong negative correlation between serum 25(OH)D levels and sarcopenia in women. Still, no such association was observed in men. In contrast, a cross-sectional study by Luo et al,58 which included 4236 participants aged 50 years and older, indicated that vitamin D insufficiency (serum 25(OH)D < 20 ng/mL) was an independent risk factor for sarcopenia in men. In contrast, no significant correlation was observed in women.

Studies have similarly indicated an association between vitamin D deficiency and sarcopenia in the context of specific diseases. For example, a study by Hori et al64 in hemodialysis patients found that vitamin D deficiency (serum 25(OH)D < 10 ng/mL) was significantly associated with sarcopenia (OR = 5.60, 95% CI: 1.52–20.57). Similarly, low vitamin D levels were also found to be strongly associated with a high prevalence of sarcopenia in patients with type 2 diabetes mellitus,65 patients with chronic liver disease,66,67 female patients with rheumatoid arthritis,68 and patients with hip fragility fractures.69

It is nevertheless noteworthy that not all studies have yielded consistent results. For example, a cross-sectional study of 101 patients with stage 3 and 4 chronic kidney disease by Alvarez Mejía et al70 found no association between sarcopenia alone and serum vitamin D levels. However, a direct association was observed between vitamin D deficiency and the presence of severe sarcopenia. Furthermore, a cohort study by Gielen et al71 did not identify a notable elevation in the risk of sarcopenia with baseline vitamin D levels. Similarly, a study by Umakanthan et al72 in dialysis patients did not discern a substantial correlation between vitamin D levels and sarcopenia.

In conclusion, most available studies indicate that vitamin D deficiency is a significant risk factor for sarcopenia in older adults. However, the inconsistency of diagnostic criteria for sarcopenia and the variability in cut-off values for determining vitamin D deficiency must be considered when interpreting the results of these studies. Therefore, using uniform diagnostic criteria and judgmental thresholds in future studies will facilitate the accurate revelation of the association between vitamin D deficiency and sarcopenia.

Mechanism of Vitamin D in the Pathogenesis of Sarcopenia in the Senior People Promoting Muscle Protein Synthesis

Vitamin D is important in promoting muscle protein synthesis. This is primarily achieved through the activation of the VDR, which binds to specific DNA sequences and regulates the expression of genes associated with protein synthesis.73–76 These genes encode enzymes and factors necessary for muscle protein synthesis, essential for muscle growth and repair.77,78 Vitamin D deficiency can decrease the rate of muscle protein synthesis, reducing muscle mass.74,79

Vitamin D helps maintain calcium ion balance in muscle cells and reinforces the signaling role of calcium ions, which is critical for protein synthesis.80 Vitamin D regulates metabolic processes within muscle cells, optimizing energy metabolic pathways to provide sufficient energy and substrates for muscle protein synthesis.81–84 It also reduces muscle cell apoptosis and enhances cell survival, thereby maintaining muscle mass and protein synthesis capacity.85–87 In sarcopenia, increased apoptosis of muscle cells is a critical pathological change. Vitamin D interacts with other nutrients and hormones to enhance its effect on promoting muscle protein synthesis.84,88,89 These regulatory networks work together to maintain muscle health and function.

Regulation of Muscle Cell Proliferation and Differentiation

Vitamin D is essential for the proliferation and differentiation of muscle cells. Research has demonstrated that vitamin D can effectively promote the proliferation and differentiation of muscle stem cells.75,78,90 These cells play a crucial role in muscle regeneration and repair processes. Without sufficient vitamin D, the proliferation and differentiation of muscle stem cells may be hindered, negatively impacting muscle regeneration.73 Vitamin D binds to the VDR and forms a heterodimer with the retinoic acid X receptor (RXR). This heterodimer then binds to vitamin D response elements (VDREs) located in the promoter regions of muscle-associated genes, directly regulating their transcriptional activity.91–93

Activation of key regulators, such as cell cycle proteins and cell cycle-dependent kinases, achieves proliferation. Vitamin D significantly promotes the proliferation of muscle satellite cells, which supply new muscle fibers in response to muscle damage or growth demands.80,84,90,94 The stimulatory effect of vitamin D increases the number and activity of satellite cells, thereby aiding muscle regeneration and repair.76,84,94 Regarding differentiation, vitamin D upregulates the expression of muscle-specific genes, such as myosin heavy chain (MyHC) and muscle creatine kinase (MCK), promoting muscle cell differentiation and maturation.95 Additionally, vitamin D significantly enhances myoblast differentiation, as demonstrated by increased expression of differentiation markers, including myogenin and troponin T type 1.84 These effects contribute to the transition of muscle cells from a proliferative state to mature muscle fibers, enhancing muscle mass and strength.88,90 Additionally, vitamin D may influence muscle contractile and diastolic processes by modulating calcium ion homeostasis within muscle cells.80,96 Vitamin D regulates the reabsorption and utilization of calcium ions, key signaling molecules for muscle contraction, within muscle cells, ensuring the regular maintenance of muscle function.73

Impact on Mitochondrial Function

The proper functioning of mitochondria is critical for muscle function and strength as they are an essential energy supply center within muscle cells. Vitamin D significantly influences mitochondrial function and metabolism through its unique regulatory mechanisms.97–99 When vitamin D binds to intracellular receptors (VDRs), it activates a series of signaling pathways that regulate mitochondrial production and function.97,98,100 Vitamin D plays a crucial role in maintaining the stability and function of mitochondrial DNA. Mitochondrial DNA encodes vital proteins within the mitochondria, and its integrity is essential for mitochondrial function. Vitamin D facilitates mitochondrial DNA synthesis and repair processes, ensuring accurate transmission of genetic information and functional execution.101

Vitamin D regulates mitochondrial energy metabolism. Mitochondria produce ATP through oxidative phosphorylation, providing essential energy for muscle cells. Studies have shown that vitamin D supplementation significantly improves mitochondrial oxidative phosphorylation in vitamin D-deficient skeletal muscle, increasing the efficiency of mitochondrial energy production.102 Vitamin D deficiency may inhibit mitochondrial energy metabolism, leading to insufficient energy supply to muscle cells and affecting normal muscle function.84,97,98,100 Vitamin D has antioxidant properties that can reduce intracellular oxidative stress, protecting mitochondria from damage.98,100,103 Oxidative stress is typically the result of an imbalance between the overproduction of reactive oxygen species (ROS) and the cell’s antioxidant mechanism. Vitamin D has an antioxidant effect that effectively reduces ROS production and helps maintain mitochondria’s structural and functional integrity.97,102,104,105 Additionally, vitamin D’s metabolic role in skeletal muscle cells may be interrelated with its effect on mitochondrial function. Vitamin D is crucial in maintaining calcium ion homeostasis, which regulates muscle energy metabolism.98,106 Optimizing calcium ion homeostasis enhances the functional state of mitochondria.

Regulation of Immune and Inflammatory Responses

Vitamin D plays a critical role in regulating immune and inflammatory responses. Chronic inflammation exacerbates muscle cell damage and apoptosis in the pathological process of sarcopenia.107 Vitamin D intervention can significantly mitigate this process.108 As a critical immunomodulatory factor, vitamin D regulates the function and activity of a wide range of immune cells by interacting with its receptor (VDR).20,109 In the context of sarcopenia, vitamin D promotes the activity of anti-inflammatory cells, such as regulatory T cells and macrophages, while suppressing the production of inflammatory cells, such as Th17 cells and cytotoxic T cells.20,109 This helps to achieve a dynamic balance in the immune system.

Additionally, vitamin D attenuates the inflammatory response by modulating inflammatory factors released by immune cells. In sarcopenia, chronic inflammation is a significant factor contributing to muscle damage and loss of muscle mass.107 Vitamin D inhibits the production of pro-inflammatory cytokines, such as IFN-γ, IL-1, 6, 12, 18, and TNF-α, which have direct catabolic effects on muscle cells and inhibit muscle protein synthesis.110 Vitamin D effectively alleviates the inflammatory response and reduces the symptoms of sarcopenia by lowering the levels of inflammatory factors. Studies have shown that vitamin D deficiency leads to increased expression of TNFα, matrix metalloproteinase 3 (MMP3), and IL-6 in mouse muscle, further validating the critical role of vitamin D in regulating inflammatory responses.111

Other Mechanisms

In addition to the characteristics above, vitamin D may play a crucial role in the development of sarcopenia by affecting the ratio and transformation of muscle fiber types. Sarcopenia is often characterized by a decrease in fast muscle fibers and a relative increase in slow muscle fibers. Vitamin D regulates the expression of specific genes and related signaling pathways, affecting the muscle fiber type transition process and ultimately impacting muscle function and strength.112–114

Additionally, Vitamin D is involved in regulating apoptosis and autophagy processes in muscle cells. In sarcopenia, increased apoptosis and abnormal autophagy in muscle cells may lead to significant loss of muscle mass. Vitamin D regulates the expression of apoptosis—and autophagy-related genes, which helps maintain the balance between muscle cell survival and death.75,115,116

It also plays a vital role in the repair process after muscle damage. In cases of sarcopenia, the weakened ability of muscle cells to repair damage may lead to a further decline in muscle function. Vitamin D may enhance the repair and regeneration of muscle damage by promoting muscle cell proliferation, differentiation, and migration.117,118

In conclusion, vitamin D exerts its influence on muscle health through a multitude of mechanisms, including the stimulation of muscle protein synthesis, the regulation of muscle cell proliferation and differentiation, the maintenance of mitochondrial function, the modulation of immune and inflammatory responses, and a number of additional mechanisms. Collectively, these mechanisms elucidate the pivotal role of vitamin D in the maintenance of muscle health (Figure 1). However, it is essential to note that these aspects are based on current research and theoretical speculations. Further research and validation are necessary to fully understand vitamin D’s role in the pathogenesis of sarcopenia. The process involves multiple complex signaling pathways and molecular interactions, making it multi-dimensional and intricate.

Figure 1 Mechanisms of vitamin D in the pathogenesis of sarcopenia in the senior people.

Comprehensive Prevention and Treatment Strategies for Sarcopenia Nutritional Interventions

Vitamin D is primarily obtained through sun exposure and food consumption. Good sources of vitamin D include cod liver oil, milk, and eggs.119–121 However, the body’s vitamin D production is affected by various factors, such as age, race, skin condition, environmental factors (such as sunlight intensity and latitude), and individual behaviors (such as duration of sun exposure and use of sunscreen).25,37 Due to seasonal, geographic, and dietary constraints, obtaining sufficient vitamin D from food alone is difficult. Therefore, individuals with sarcopenia should take vitamin D supplements in appropriate amounts and under the guidance of a physician or a dietitian.

Numerous studies have demonstrated the beneficial effects of vitamin D on muscle strength and function in the senior people.122–125 Additionally, combined calcium and vitamin D supplementation has been found to improve many muscle strength indicators significantly.126 Randomized controlled trials have confirmed the importance of vitamin D for skeletal muscle function and general health.127 Animal model studies have demonstrated the potential therapeutic benefits of diet and vitamin D supplementation on muscle health.87,128

Therefore, it is essential to adjust the intake of vitamin D individually. The recommended daily intake for adults is generally 400–800 international units (IU).122 However, individuals with severe vitamin D deficiency and those with sarcopenia may require higher doses.18 The senior people, in particular, should consider supplementing with at least 800–1000 IU/day of vitamin D.129 Studies have shown that vitamin D supplementation through food fortification, such as vitamin D-fortified milk, significantly improves vitamin D status.130 This suggests the potential of food sources to enhance muscle health. Double-blind, randomized controlled trials have shown that nutritional interventions targeting the senior people with sarcopenia, such as fortified foods containing 1,000 IU of vitamin D, improve their handgrip strength and stride speed.131 Therefore, proper intake of vitamin D is essential for maintaining muscle health.

In treating sarcopenia, the synergistic effect of other nutrients with vitamin D is equally significant. Protein, an essential building block for muscle growth and repair, works with vitamin D to effectively promote muscle mass.132 Ensuring adequate protein intake is necessary for senior people to maintain muscle mass and function.133,134 Whey protein is a valuable source of high-quality protein due to its ease of digestion and richness in all essential amino acids, particularly leucine, a crucial activator of muscle protein synthesis.135 According to a study by Ottestad et al,136 protein-enriched milk positively impacted the senior people aged 70 years or older with reduced physical strength or mobility, significantly improving their body composition and muscle strength.

Vitamin D and leucine have been shown to have synergistic effects in promoting protein anabolism.137–139 Therefore, combining whey protein with vitamin D supplementation may further improve gait speed in the senior people with sarcopenia.140 It is important to note that the synergistic effects of multiple nutrients, including vitamin D, with protein sources, may produce even more significant results. For instance, a 12–13 week intervention study showed that the senior people with sarcopenia experienced substantial improvements in muscle mass, lower extremity strength, and function when supplemented with vitamin D and leucine-rich whey protein, mainly when adequate protein intake.138,140,141 Furthermore, fortified dairy products have the potential to enhance skeletal muscle health as a nutrient-dense food.142 These dairy products are fortified with vitamin D and rich in protein and various micronutrients, such as vitamin B12, calcium, riboflavin, and zinc, essential for maintaining muscle health and function.143 It is worth noting that normalizing circulating vitamin D concentrations may be a critical factor in the efficacy of protein supplements.124

In nutritional interventions for sarcopenia, it is essential to focus on a balanced intake of nutrients, including calcium and phosphorus, which are crucial in maintaining bone and muscle health.28 Avoiding excessive fat and sugar intake is also necessary, as they may adversely affect muscle health. Therefore, individuals diagnosed with sarcopenia are advised to control their daily fat and sugar intake while increasing their fiber—and vitamin-rich fruits and vegetables to maintain a healthy diet.

Sports Interventions

Resistance exercise,144 low-impact aerobic exercise,145 and balance training146 are recommended for older adults. These activities have been shown to alleviate or improve the symptoms of sarcopenia and enhance overall physical functioning and quality of life in this population.

Currently, there is a lack of safe pharmacological treatments for sarcopenia. Nutritional interventions and exercise training are recognized as effective non-pharmacological therapies, but their exact effects are still under investigation.147 Exercise can effectively stimulate muscle growth and metabolic processes, while nutrition is an indispensable source of energy and raw materials for muscle maintenance and repair. It is essential to replenish energy and nutrients after exercise for optimal muscle repair and growth, particularly for older individuals.

While whey protein, leucine, and vitamin D supplements can promote muscle health without physical activity, combining them with aerobic or resistance training can significantly enhance muscle mass, strength, and functional performance.148–151 Furthermore, physical activity can enhance the effects of branched-chain amino acid (BCAA) and protein supplementation. Muscle proteolysis during exercise releases essential amino acids, promoting protein synthesis.152 Research has demonstrated that the combination of vitamin D and physical activity may have potentially positive effects on muscle function, particularly in the senior people.52 Guidelines for treating sarcopenia recommend incorporating resistance exercise (RE), optimizing protein intake, and addressing vitamin D insufficiency or deficiency.2 However, the optimal way to combine these variables remains unclear. Consuming fortified dairy products after resistance training can help improve muscle strength for the senior people.153 Meta-analyses have shown that maintaining a daily protein intake of 1.2–1.59 g/kg body weight in combination with resistance exercise training positively affects lean body mass and muscle function in the senior people.154 Additionally, studies have found that vitamin D supplementation increases physical activity levels.155

In conclusion, exercise and nutrition have a synergistic effect that effectively prevents and treats sarcopenia, improving the physical fitness and health of the senior people. However, it is essential to note that exercise and nutrition programs should be personalized according to individual differences. Seek guidance from professional health managers or doctors when necessary.

Drug Interventions

Various vitamin D preparations exist, such as calcitriol, alfacalcidol, calcifediol, and eldecalcitol. These medications are typically administered orally, and a combination of individual patient and physician recommendations should determine their exact dosage and use. Vitamin D preparations should be taken regularly over a long period to achieve a stable therapeutic effect. Studies have shown that supplementation with calcitriol156 or eldecalcitol157 can effectively reduce the risk and number of falls in the senior people. Calcifediol is a suitable treatment option for patients with all types of vitamin D deficiency, particularly those with obesity, liver disease, and malabsorption.158 Eldecalcitol, a novel vitamin D analog, has a stronger affinity for vitamin D-binding protein (DBP) and a weaker affinity for the VDR than alfacalcidol. According to a study by Saito et al,159 eldecalcitol positively improved quadriceps and back extensor muscle strength.

However, caution should be exercised regarding the potential side effects of vitamin D supplementation. Despite its numerous benefits, excessive vitamin D intake can also have adverse consequences.160 The most frequent side effect is hypercalcemia, an abnormally high level of calcium in the blood, which can cause digestive symptoms such as nausea, vomiting, and diarrhea and may even result in serious health issues such as kidney stones and heart arrhythmia.161 When supplementing with vitamin D, strictly following your doctor’s or dietitian’s advice is crucial. The dose, frequency, and duration of supplementation should be precisely determined based on factors such as serum (25(OH)D) concentration, patient type, therapeutic conditions, and comorbidities such as obesity and malabsorption syndromes. This will help avoid the risk of overdosage.

Significant progress has been made in the pharmacologic treatment of sarcopenia, in addition to vitamin D preparations. New drugs such as muscle growth factor, anti-sarcopenia protein, and irisin have attracted much attention recently.162–165 These drugs act directly on muscle cells, effectively promoting muscle growth and repair, opening up a new path for sarcopenia treatment. Meanwhile, hormonal drugs and immunosuppressants play a crucial role in treating sarcopenia by regulating the immune system function and reducing the inflammatory response, significantly improving muscle condition.166–168 Studies have also shown that overactivity of the renin-angiotensin system has adverse effects on the neuromusculoskeletal and cardiovascular systems. The combination of angiotensin-converting enzyme inhibitors and vitamin D has positively impacted physical and cognitive function, making it an effective strategy for treating sarcopenia in the senior people.169 However, the use of these drugs requires strict management of indications and contraindications to avoid potential risks.

In conclusion, a combined prevention and treatment strategy involving vitamin D, in isolation or in combination with exercise and medication, is of significant importance in the management of sarcopenia. This approach can effectively enhance the muscle status and quality of life of patients with sarcopenia (Table 2).

Table 2 Effectiveness of Vitamin D Alone and in Combination with Other Interventions

Outlook for Future Research Directions Molecular Mechanisms of Vitamin D in Sarcopenia

Future research should investigate the specific molecular mechanisms of vitamin D in sarcopenia, including its effects on muscle cell growth, differentiation, function, and protein synthesis and degradation. Elucidating these mechanisms will enhance our understanding of the therapeutic potential of vitamin D in sarcopenia.

Study of Genes Associated with Vitamin D and Sarcopenia

Genes play an essential role in the pathogenesis and treatment of sarcopenia. Future studies can further explore the interactions between vitamin D and sarcopenia-related genes, such as the relationship between vitamin D receptor gene polymorphisms and sarcopenia. This will help to reveal the genetic basis of sarcopenia and provide a theoretical basis for the development of targeted therapies.

Large-Scale Clinical Trials

In addition to the need for further verification of the therapeutic effects of vitamin D supplementation in sarcopenia due to the small sample sizes of previous studies, it is also essential to consider the potential benefits of vitamin D in other conditions related to muscle health. Given the possible role of vitamin D in muscle health, it is crucial to conduct future large-scale, multicenter clinical trials to assess vitamin D’s efficacy and safety in treating sarcopenia.

Research on Special Populations

The existing research on vitamin D and sarcopenia has predominantly concentrated on the general population, overlooking the specific needs and responses of special populations such as the senior people, chronically ill, and bedridden individuals. These unique populations may have distinct physical conditions that could influence their requirements for vitamin D. Consequently; future research must prioritize investigating vitamin D’s effects on these particular populations to develop more tailored treatment options that address their specific circumstances.

Combination of Vitamin D with Other Nutrients or Drugs

Vitamin D may have synergistic effects with other nutrients or drugs in the treatment of sarcopenia. Future studies could explore the impact of combining vitamin D with nutrients such as proteins, calcium, and antioxidants and the interactions between vitamin D and drugs such as hormones and immunosuppressants. Healthcare professionals can develop more effective and personalized treatment approaches for sarcopenia and related conditions by understanding how vitamin D interacts with various nutrients and drugs.

Prospects and Challenges for Clinical Applications

The clinical application of vitamin D to treat sarcopenia is promising despite challenges. Determining the appropriate dosage of vitamin D supplementation and avoiding side effects associated with excessive intake are important considerations. Additionally, the duration of supplementation is an essential aspect to consider in the clinical application of vitamin D for sarcopenia. Furthermore, it is essential for future research to explore the potential synergistic effects of vitamin D supplementation with other interventions, such as exercise or specific dietary modifications. Future studies will undoubtedly advance the clinical application of vitamin D in the treatment of sarcopenia by addressing practical issues and providing specific solutions and recommendations.

In summary, many unanswered questions regarding the relationship between vitamin D and sarcopenia still require further exploration. By conducting in-depth research on its molecular mechanism, gene action, large-scale clinical trials, and studies on special populations, we can establish a more robust scientific basis for treating sarcopenia. Focusing on the prospects and challenges of clinical applications will help translate research results into practical treatment programs, improving the quality of life for patients with sarcopenia.

Conclusion

In conclusion, there is a robust correlation between vitamin D and sarcopenia in older adults, with existing studies providing varying degrees of support for this association. Vitamin D, a crucial fat-soluble vitamin, plays a pivotal role in calcium and phosphorus metabolism and the maintenance of bone health. Additionally, it is instrumental in muscle growth and functional maintenance. A comprehensive analysis of existing studies revealed that vitamin D deficiency represents a significant risk factor for sarcopenia in older adults. The majority of studies have demonstrated a significant correlation between low vitamin D levels and the prevalence of sarcopenia. Vitamin D supplementation has also been shown to enhance muscle strength and function. Despite differences in sample selection, diagnostic criteria, and definition of vitamin D deficiency across studies, the overall trend suggests a potential role for vitamin D in the prevention and management of sarcopenia. Additionally, vitamin D affects muscle health through various mechanisms, including promoting muscle protein synthesis, regulating muscle cell proliferation and differentiation, maintaining mitochondrial function, and modulation of immune and inflammatory responses. These mechanisms collectively elucidate vitamin D’s crucial role in maintaining muscle health.

A comprehensive approach to preventing and treating sarcopenia should encompass nutritional interventions, exercise, and pharmacological agents. Senior people need to consume a reasonable amount of vitamin D, which plays a significant role in nutritional intervention. It is also imperative to underscore the necessity of appropriate exercise and pharmacological treatment programs for senior people. These strategies have been demonstrated to improve muscle status and enhance quality of life in patients with sarcopenia. Further research is required to elucidate the precise mechanism of action of vitamin D in sarcopenia. Additionally, large-scale, multicenter clinical trials are necessary to confirm the efficacy and safety of vitamin D supplementation in treating sarcopenia. Furthermore, it is essential to consider the vitamin D requirements and intervention effects in specific populations, such as patients with chronic diseases and bedridden individuals, to develop more personalized and precise treatment plans.

In conclusion, the relationship between vitamin D and sarcopenia is of significant scientific and practical importance. Further research in this area and the development of comprehensive prevention and treatment strategies can devise new ideas and methods for preventing and treating sarcopenia, thus improving seniors’ overall health and quality of life.

Acknowledgments

The authors wish to thank all hands and minds involved in this review.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

This work was supported by the Key Talents Project of Changzhou Third People’s Hospital.

Disclosure

The authors declare no conflicts of interest in this study.

References

1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9

2. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169

3. Larsson L, Degens H, Li M, et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol Rev. 2019;99(1):427–511. doi:10.1152/physrev.00061.2017

4. Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1–7. doi:10.1097/MCO.0b013e328333c1c1

5. Landi F, Calvani R, Cesari M, et al. Sarcopenia as the biological substrate of physical frailty. Clin Geriatr Med. 2015;31(3):367–374. doi:10.1016/j.cger.2015.04.005

6. Sobestiansky S, Michaelsson K, Cederholm T. Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85-89 year old community-dwelling men: a report from the ULSAM study. BMC Geriatr. 2019;19(1):318. doi:10.1186/s12877-019-1338-1

7. Yeung SSY, Reijnierse EM, Pham VK, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485–500. doi:10.1002/jcsm.12411

8. Xu J, Wan CS, Ktoris K, Reijnierse EM, Maier AB. Sarcopenia Is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361–376. doi:10.1159/000517099

9. Reiss J, Iglseder B, Alzner R, et al. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age Ageing. 2019;48(5):719–724. doi:10.1093/ageing/afz035

10. Locquet M, Beaudart C, Petermans J, Reginster JY, Bruyère O. EWGSOP2 Versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc. 2019;20(3):384–385. doi:10.1016/j.jamda.2018.11.027

11. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129–133. doi:10.1007/s13539-010-0014-2

12. Wojzischke J, van Wijngaarden J, van den Berg C, et al. Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur Geriatr Med. 2020;11(2):195–207. doi:10.1007/s41999-020-00294-2

13. Ligthart-Melis GC, Luiking YC, Kakourou A, Cederholm T, Maier AB, de van der Schueren MAE. Frailty, sarcopenia, and malnutrition frequently (Co-)occur in hospitalized older adults: a systematic review and meta-analysis. J Am Med Dir Assoc. 2020;21(9):1216–1228. doi:10.1016/j.jamda.2020.03.006

14. Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol. 2012;24(6):623–627. doi:10.1097/BOR.0b013e328358d59b

15. Robinson SM, Reginster JY, Rizzoli R, et al. Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr. 2018;37(4):1121–1132. doi:10.1016/j.clnu.2017.08.016

16. Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533. doi:10.1016/j.metabol.2023.155533

17. Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab. 2018;72(2):87–95. doi:10.1159/000486536

18. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. doi:10.1056/NEJMra070553

19. Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin d: current evidence and outstanding questions. Endocr Rev. 2019;40(4):1109–1151. doi:10.1210/er.2018-00126

20. Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020;12(7):2097. doi:10.3390/nu12072097

21. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357–1364. doi:10.3945/ajcn.111.031070

22. Zhang RH, He DH, Zhou B, et al. Analysis of vitamin D status in men highly exposed to sunlight. Biomed Environ Sci. 2015;28(12):913–916. doi:10.3967/bes2015.125

23. Ponchon G, Kennan AL, DeLuca HF. “Activation” of vitamin D by the liver. J Clin Invest. 1969;48(11):2032–2037. doi:10.1172/JCI106168

24. Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96(4):507–515. doi:10.1016/S0092-8674(00)80655-8

25. Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34(1):33–83. doi:10.1210/er.2012-1012

26. Dzik KP, Kaczor JJ. Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state. Eur J Appl Physiol. 2019;119(4):825–839. doi:10.1007/s00421-019-04104-x

27. Shimizu Y, Kim H, Yoshida H, Shimada H, Suzuki T. Serum 25-hydroxyvitamin D level and risk of falls in Japanese community-dwelling elderly women: a 1-year follow-up study. Osteoporos Int. 2015;26(8):2185–2192. doi:10.1007/s00198-015-3130-1

28. Giustina A, Bouillon R, Dawson-Hughes B, et al. Vitamin D in the older population: a consensus statement. Endocrine. 2023;79(1):31–44. doi:10.1007/s12020-022-03208-3

29. Boettger SF, Angersbach B, Klimek CN, et al. Prevalence and predictors of vitamin D-deficiency in frail older hospitalized patients. BMC Geriatr. 2018;18(1):219. doi:10.1186/s12877-018-0919-8

30. Verlaan S, Aspray TJ, Bauer JM, et al. Nutritional status, body composition, and quality of life in community-dwelling sarcopenic and non-sarcopenic older adults: a case-control study. Clin Nutr. 2017;36(1):267–274. doi:10.1016/j.clnu.2015.11.013

31. Alagöl F, Shihadeh Y, Boztepe H, et al. Sunlight exposure and vitamin D deficiency in Turkish women. J Endocrinol Invest. 2000;23(3):173–177. doi:10.1007/BF03343702

32. Loomis WF. Skin-pigment regulation of vitamin-D biosynthesis in man. Science. 1967;157(3788):501–506. doi:10.1126/science.157.3788.501

33. Zakharova I, Klimov L, Kuryaninova V, et al. Vitamin D insufficiency in overweight and obese children and adolescents. Front Endocrinol. 2019;10:103. doi:10.3389/fendo.2019.00103

34. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76(4):1536–1538. doi:10.1172/JCI112134

35. Lips P, Bilezikian JP, Bouillon RVD. Giveth to Those Who Needeth. JBMR Plus. 2020;4(1):e10232. doi:10.1002/jbm4.10232

36. Cashman KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int. 2020;106(1):14–29. doi:10.1007/s00223-019-00559-4

37. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res. 2004;19(2):265–269. doi:10.1359/jbmr.2004.19.2.265

38. Si Y, Kazamel M, Kwon Y, et al. The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis. J Steroid Biochem Mol Biol. 2020;200:105650. doi:10.1016/j.jsbmb.2020.105650

39. Malczewska-Lenczowska J, Sitkowski D, Surała O, Orysiak J, Szczepańska B, Witek K. The association between iron and vitamin D status in female elite athletes. Nutrients. 2018;10(2):167. doi:10.3390/nu10020167

40. Atkinson MA, Melamed ML, Kumar J, et al. Vitamin D, race, and risk for anemia in children. J Pediatr. 2014;164(1):153–158.e151. doi:10.1016/j.jpeds.2013.08.060

41. Perlstein TS, Pande R, Berliner N, Vanasse GJ. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood. 2011;117(10):2800–2806. doi:10.1182/blood-2010-09-309708

42. Houston DK, Cesari M, Ferrucci L, et al. Association between vitamin D status and physical performance: the InCHIANTI study. J Gerontol a Biol Sci Med Sci. 2007;62(4):440–446. doi:10.1093/gerona/62.4.440

43. Janssen HC, Emmelot-Vonk MH, Verhaar HJ, van der Schouw YT. Vitamin D and muscle function: is there a threshold in the relation? J Am Med Dir Assoc. 2013;14(8):627.e613–628. doi:10.1016/j.jamda.2013.05.012

44. Mizuno T, Hosoyama T, Tomida M, et al. Influence of vitamin D on sarcopenia pathophysiology: a longitudinal study in humans and basic research in knockout mice. J Cachexia Sarcopenia Muscle. 2022;13(6):2961–2973. doi:10.1002/jcsm.13102

45. Orces CH. Prevalence of clinically relevant muscle weakness and its association with vitamin D status among older adults in Ecuador. Aging Clin Exp Res. 2017;29(5):943–949. doi:10.1007/s40520-016-0678-3

46. Wang J, Wang X, Gu Y, et al. Vitamin D is related to handgrip strength in adult men aged 50 years and over: a population study from the TCLSIH cohort study. Clin Endocrinol. 2019;90(5):753–765. doi:10.1111/cen.13952

47. Mendoza-Garcés L, Velázquez-Alva MC, Cabrer-Rosales MF, Arrieta-Cruz I, Gutiérrez-Juárez R, Irigoyen-Camacho ME. Vitamin D deficiency is associated with handgrip strength, nutritional status and T2DM in community-dwelling older Mexican women: a cross-sectional study. Nutrients. 2021;13(3). doi:10.3390/nu13030736

48. Iolascon G, de Sire A, Calafiore D, Moretti A, Gimigliano R, Gimigliano F. Hypovitaminosis D is associated with a reduction in upper and lower limb muscle strength and physical performance in post-menopausal women: a retrospective study. Aging Clin Exp Res. 2015;27(1):S23–30. doi:10.1007/s40520-015-0405-5

49. Levinger P, Begg R, Sanders KM, et al. The effect of vitamin D status on pain, lower limb strength and knee function during balance recovery in people with knee osteoarthritis: an exploratory study. Arch Osteoporos. 2017;12(1):83. doi:10.1007/s11657-017-0378-4

50. Aspell N, Laird E, Healy M, Lawlor B, O’Sullivan M. Vitamin D deficiency is associated with impaired muscle strength and physical performance in community-dwelling older adults: findings from the English longitudinal study of ageing. Clin Interv Aging. 2019;14:1751–1761. doi:10.2147/CIA.S222143

51. Ceglia L. Vitamin D and its role in skeletal